Nuclera, a UK-based biotechnology company accelerating protein expression and optimisation through its benchtop eProtein Discovery System, has established a distribution network across Asia Pacific (APAC) and the Middle East. Marking a key milestone in the company’s global commercial strategy, the expansion establishes new regional distribution networks, providing localised technical support for customers in these key markets.
In response to the rapidly growing demand for its innovative eProtein Discovery System, Nuclera has formed partnerships with seven channel partners: MineBio Life Sciences Ltd (China), Kiko Tech Co.,Ltd (Japan), CHAYON Laboratories, Inc. (South Korea), Sciencewerke Pte Ltd (Singapore), Cold Spring Biotech (Taiwan) and Yair Or Technologies Ltd (Israel). These new partnerships follow the recent expansion of the eProtein Discovery System, which now enables discovery of both membrane and soluble proteins.
Proteins represent 95% of drug targets designed to combat disease therefore developing reliable and efficient methods to identify how to express soluble and active proteins of interest is a crucial aspect of the drug discovery process. Researchers are realizing the value of systems, such as eProtein Discovery, that streamline protein production and enable rapid, scalable access to high-quality proteins, across cell-free and cell-based expression methods.
